• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于神经影像学发现理解阿尔茨海默病的认知缺陷。

Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

机构信息

Imaging Genetics Center, Laboratory of Neuro Imaging, Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA.

出版信息

Trends Cogn Sci. 2013 Oct;17(10):510-6. doi: 10.1016/j.tics.2013.08.007. Epub 2013 Sep 9.

DOI:10.1016/j.tics.2013.08.007
PMID:24029445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3947610/
Abstract

Brain amyloid can be measured using positron emission tomography (PET). There are mixed reports regarding whether amyloid measures are correlated with measures of cognition (in particular memory), depending on the cohorts and cognitive domains assessed. In Alzheimer's disease (AD) patients and those at heightened risk for AD, cognitive performance may be related to the level and extent of classical AD pathology (amyloid plaques and neurofibrillary angles), but it is also influenced by neurodegeneration, neurocognitive reserve, and vascular health. We discuss what recent neuroimaging research has discovered about cognitive deficits in AD and offer suggestions for future research.

摘要

脑淀粉样蛋白可以通过正电子发射断层扫描(PET)进行测量。根据评估的队列和认知领域的不同,淀粉样蛋白测量值与认知(特别是记忆)测量值是否相关存在混合报告。在阿尔茨海默病(AD)患者和 AD 高危人群中,认知表现可能与经典 AD 病理(淀粉样斑块和神经纤维缠结)的水平和程度有关,但也受到神经退行性变、神经认知储备和血管健康的影响。我们讨论了最近神经影像学研究对 AD 认知缺陷的发现,并为未来的研究提供了建议。

相似文献

1
Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.基于神经影像学发现理解阿尔茨海默病的认知缺陷。
Trends Cogn Sci. 2013 Oct;17(10):510-6. doi: 10.1016/j.tics.2013.08.007. Epub 2013 Sep 9.
2
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.认知和神经影像学特征以及阿尔茨海默病风险个体的脑β-淀粉样蛋白(INSIGHT-preAD):一项纵向观察性研究。
Lancet Neurol. 2018 Apr;17(4):335-346. doi: 10.1016/S1474-4422(18)30029-2. Epub 2018 Feb 27.
3
Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.淀粉样蛋白病理和神经退行性变对认知正常成年人认知变化的影响。
Brain. 2018 Aug 1;141(8):2475-2485. doi: 10.1093/brain/awy150.
4
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.肝酶改变与阿尔茨海默病诊断、认知、神经影像学指标和脑脊液生物标志物的关联。
JAMA Netw Open. 2019 Jul 3;2(7):e197978. doi: 10.1001/jamanetworkopen.2019.7978.
5
Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.教育对健康对照者、轻度认知障碍和阿尔茨海默病患者阿尔茨海默病相关神经影像学生物标志物的影响:一项横断面研究。
J Alzheimers Dis. 2018;63(2):861-869. doi: 10.3233/JAD-171168.
6
Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.与临床前阿尔茨海默病当前神经影像学生物标志物相关的认知和脑图谱
J Neurosci. 2015 Jul 22;35(29):10402-11. doi: 10.1523/JNEUROSCI.0150-15.2015.
7
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.脑β-淀粉样蛋白测量和磁共振成像萎缩均能预测从轻度认知障碍到阿尔茨海默病的进展时间。
Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.
8
18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.18F-Flortaucipir PET 与阿尔茨海默病导致的轻度认知障碍患者的脑脊液、认知和神经影像学的相关性。
J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.
9
Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.生活方式和血管危险因素与中年期阿尔茨海默病脑生物标志物变化的关联:大纽约地区一项为期 3 年的纵向研究。
BMJ Open. 2018 Nov 25;8(11):e023664. doi: 10.1136/bmjopen-2018-023664.
10
The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.载脂蛋白 E4 联合年龄和阿尔茨海默病评估量表 - 认知分量表可改善对临床诊断为轻度认知障碍患者的淀粉样蛋白正电子发射断层扫描状态的预测。
Eur J Neurol. 2019 May;26(5):733-e53. doi: 10.1111/ene.13881. Epub 2019 Jan 20.

引用本文的文献

1
Regular physical activity affects brain activities in old individuals: an observational study.规律的体育活动对老年人的大脑活动有影响:一项观察性研究。
PLoS One. 2025 Jul 2;20(7):e0326163. doi: 10.1371/journal.pone.0326163. eCollection 2025.
2
Gintonin Binds to Reduced LPA4 Receptor Subtype in Human Cortical Neurons in Alzheimer's Disease Brains.人参炔醇与阿尔茨海默病大脑中人类皮质神经元中失活的LPA4受体亚型结合。
Biomolecules. 2025 Jan 26;15(2):179. doi: 10.3390/biom15020179.
3
Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer's disease.认知变化反映了阿尔茨海默病中的淀粉样蛋白、tau蛋白和神经退行性生物标志物。
Geroscience. 2025 Jan 28. doi: 10.1007/s11357-025-01541-9.
4
Free-water: A promising structural biomarker for cognitive decline in aging and mild cognitive impairment.游离水:一种用于衰老和轻度认知障碍中认知衰退的有前景的结构生物标志物。
Imaging Neurosci (Camb). 2024 Sep 18;2:1-16. doi: 10.1162/imag_a_00293. eCollection 2024 Sep 1.
5
Association of plasma biomarkers with cognitive function in persons with dementia and cognitively healthy in the Democratic Republic of Congo.刚果民主共和国痴呆症患者和认知健康者血浆生物标志物与认知功能的关联
Alzheimers Dement (Amst). 2023 Nov 8;15(4):e12496. doi: 10.1002/dad2.12496. eCollection 2023 Oct-Dec.
6
Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model.经 FUS 增强递送低剂量 aducanumab 可改善 5×FAD 小鼠(AD 模型)的状况。
Transl Neurodegener. 2022 Dec 27;11(1):57. doi: 10.1186/s40035-022-00333-x.
7
A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages.一个错义变异在 SHARPIN 中介导了阿尔茨海默病特异性的大脑损伤。
Transl Psychiatry. 2021 Nov 16;11(1):590. doi: 10.1038/s41398-021-01680-5.
8
Metabolic disorder in Alzheimer's disease.阿尔茨海默病中的代谢紊乱。
Metab Brain Dis. 2021 Jun;36(5):781-813. doi: 10.1007/s11011-021-00673-z. Epub 2021 Feb 27.
9
CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease?CD8+ T 细胞介导的机制是否会导致多发性硬化症和阿尔茨海默病的神经认知障碍进展?
Front Immunol. 2020 Nov 19;11:566225. doi: 10.3389/fimmu.2020.566225. eCollection 2020.
10
Ginsenoside Compound K Induces Adult Hippocampal Proliferation and Survival of Newly Generated Cells in Young and Elderly Mice.人参皂苷化合物 K 可诱导年轻和老年小鼠海马区的成年神经前体细胞增殖和新生细胞存活。
Biomolecules. 2020 Mar 23;10(3):484. doi: 10.3390/biom10030484.

本文引用的文献

1
Multilocus genetic profiling to empower drug trials and predict brain atrophy.多基因遗传分析助力药物试验和预测脑萎缩。
Neuroimage Clin. 2013 Jun 13;2:827-35. doi: 10.1016/j.nicl.2013.05.007. eCollection 2013.
2
Neuroimaging, nutrition, and iron-related genes.神经影像学、营养与铁相关基因。
Cell Mol Life Sci. 2013 Dec;70(23):4449-61. doi: 10.1007/s00018-013-1369-2. Epub 2013 Jul 2.
3
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.在认知正常个体和阿尔茨海默病患者中,Aβ 沉积、皮质厚度与记忆之间的横断面和纵向关系分析。
JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062.
4
Breakdown of brain connectivity between normal aging and Alzheimer's disease: a structural k-core network analysis.正常衰老和阿尔茨海默病之间大脑连接的崩溃:结构 k 核网络分析。
Brain Connect. 2013;3(4):407-22. doi: 10.1089/brain.2012.0137.
5
Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study.ADCS MCI 多奈哌齐/维生素 E 研究影像学队列中的脑室扩大及其临床相关性。
Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):174-81. doi: 10.1097/WAD.0b013e3182677b3d.
6
Reply: The amyloid cascade is not the only pathway to AD.回复:淀粉样蛋白级联反应并非导致阿尔茨海默病的唯一途径。
Nat Rev Neurol. 2013 Jun;9(6):356. doi: 10.1038/nrneurol.2013.21-c2. Epub 2013 May 14.
7
In vivo assessment of amyloid-β deposition in nondemented very elderly subjects.在认知正常的非常老年受试者中进行淀粉样β沉积的体内评估。
Ann Neurol. 2013 Jun;73(6):751-61. doi: 10.1002/ana.23797. Epub 2013 Apr 17.
8
Effect of cognitive reserve markers on Alzheimer pathologic progression.认知储备标志物对阿尔茨海默病病理进展的影响。
Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):343-50. doi: 10.1097/WAD.0b013e3182900b2b.
9
Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.阿尔茨海默病神经退行性生物标志物与认知功能下降有关,但与认知正常的老年人中的β-淀粉样蛋白无关。
J Neurosci. 2013 Mar 27;33(13):5553-63. doi: 10.1523/JNEUROSCI.4409-12.2013.
10
Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment.微观结构的白质变化,而不是海马体萎缩,可检测到早期遗忘型轻度认知障碍。
PLoS One. 2013;8(3):e58887. doi: 10.1371/journal.pone.0058887. Epub 2013 Mar 14.